Michael Kantrowitz, Piper Sandler chief investment strategist, joins 'The Exchange' to discuss why higher rates pose the biggest risks to markets and more.

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Nektar Therapeutics (NKTR – Research Report) today and set a price target of ...

Piper Sandler Companies is gaining traction with a recovering market. Find out why PIPR stock is becoming an attractive ...

Piper Sandler dipped into the beverage sector on Tuesday by issuing new Overweight ratings on Coca-Cola (NYSE:KO) and PepsiCo ...

Piper Sandler analyst Anna Andreeva upgraded Nike (NKE) to Overweight from Neutral with a price target of $90, up from $72. The firm says that ...

Piper Sandler upgraded Amplitude and Asana to Overweight from Neutral, while highlighting trends for the software industry.

LONDON, January 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Paul Leece, Jeremi Martin and Daniel Allmomen to its energy ...

Despite recent share appreciation, Piper Sandler believes there is still significant upside for Kenvue. “Though shares have ...

Piper Sandler initiated coverage on soda stocks, rating PepsiCo (NASDAQ:PEP), Coca-Cola (NYSE:KO) “overweight,” and Neutral on Keurig Dr Pepper (NASDAQ:KDP).

BlackLine (NASDAQ:BL – Get Free Report) was downgraded by analysts at Piper Sandler from a “neutral” rating to an “underweight” rating in a research report issued on Monday,Finviz reports. They ...

Piper Sandler downgraded Biogen (BIIB) to Neutral from Overweight with a price target of $138, down from $315, following a transfer of coverage. Biogen remains in transition, as management ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...